238 related articles for article (PubMed ID: 35544684)
1. Nanomedicines Targeting Glioma Stem Cells.
Sabu A; Liu TI; Ng SS; Doong RA; Huang YF; Chiu HC
ACS Appl Mater Interfaces; 2023 Jan; 15(1):158-181. PubMed ID: 35544684
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin-ligase RNF138 may regulate p53 protein expression to regulate the self-renewal and tumorigenicity of glioma stem cells.
Chao Q; Li X; Huang Y
J Cancer Res Ther; 2023 Dec; 19(6):1636-1645. PubMed ID: 38156932
[TBL] [Abstract][Full Text] [Related]
3. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
4. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
[TBL] [Abstract][Full Text] [Related]
5. Ribosomal protein S6 promotes stem-like characters in glioma cells.
Shirakawa Y; Hide T; Yamaoka M; Ito Y; Ito N; Ohta K; Shinojima N; Mukasa A; Saito H; Jono H
Cancer Sci; 2020 Jun; 111(6):2041-2051. PubMed ID: 32246865
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein.
Sun Z; Wang L; Zhou Y; Dong L; Ma W; Lv L; Zhang J; Wang X
Cell Mol Neurobiol; 2020 Jul; 40(5):767-784. PubMed ID: 31853695
[TBL] [Abstract][Full Text] [Related]
7. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
8. Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts.
Okada M; Suzuki S; Togashi K; Sugai A; Yamamoto M; Kitanaka C
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769063
[TBL] [Abstract][Full Text] [Related]
9. NSG-70, a new glioblastoma cell line with mixed proneural-mesenchymal features, associates NOTCH1-WNT5A signaling with stem cell maintenance and angiogenesis.
Singh DK; Shivalingappa PKM; Sharma A; Mondal A; Muzumdar D; Shiras A; Bapat SA
J Neurooncol; 2022 May; 157(3):575-591. PubMed ID: 35430703
[TBL] [Abstract][Full Text] [Related]
10. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract][Full Text] [Related]
12. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.
Peng P; Zhu H; Liu D; Chen Z; Zhang X; Guo Z; Dong M; Wan L; Zhang P; Liu G; Zhang S; Dong F; Hu F; Cheng F; Huang S; Guo D; Zhang B; Yu X; Wan F
Theranostics; 2022; 12(9):4221-4236. PubMed ID: 35673564
[No Abstract] [Full Text] [Related]
13. Glioma Stem Cell Niches in Human Glioblastoma Are Periarteriolar.
Hira VVV; Aderetti DA; van Noorden CJF
J Histochem Cytochem; 2018 May; 66(5):349-358. PubMed ID: 29328867
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
15. Dual-drug loaded nanomedicine hydrogel as a therapeutic platform to target both residual glioblastoma and glioma stem cells.
Bozzato E; Tsakiris N; Paquot A; Muccioli GG; Bastiancich C; Préat V
Int J Pharm; 2022 Nov; 628():122341. PubMed ID: 36341916
[TBL] [Abstract][Full Text] [Related]
16. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
18. Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells.
Tao W; Lei H; Luo W; Huang Z; Ling P; Guo M; Wan L; Zhai K; Huang Q; Wu Q; Xu S; Zeng L; Wang X; Dong Z; Rich JN; Bao S
Neuro Oncol; 2023 Aug; 25(8):1428-1440. PubMed ID: 36521011
[TBL] [Abstract][Full Text] [Related]
19. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
20. Self‑renewal signaling pathways and differentiation therapies of glioblastoma stem cells (Review).
Jin J; Grigore F; Chen CC; Li M
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34013362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
